These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7193793)

  • 1. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of apomorphine-induced rotational behaviour by naloxone.
    Quock RM; Welsh TB
    J Pharm Pharmacol; 1981 Feb; 33(2):111-3. PubMed ID: 6111591
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of d-amphetamine and apomorphine in the hamster.
    Peterson ME; Morin LP
    Pharmacol Biochem Behav; 1984 Jun; 20(6):855-8. PubMed ID: 6540446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan.
    Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):119-30. PubMed ID: 4547506
    [No Abstract]   [Full Text] [Related]  

  • 8. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM
    Life Sci; 1982 Dec; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behavior.
    Moon BH; Feigenbaum JJ; Carson PE; Klawans HL
    Eur J Pharmacol; 1980 Jan; 61(1):71-8. PubMed ID: 7188752
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy.
    Segal DS
    Brain Res; 1976 Nov; 116(2):267-76. PubMed ID: 135600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse tolerance to stimulant-induced abnormal behavior.
    Kilbey MM; Ellinwood EH
    Life Sci; 1977 Mar; 20(6):1063-75. PubMed ID: 557715
    [No Abstract]   [Full Text] [Related]  

  • 18. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 19. Reverse tolerance to amphetamine of mice bearing unilateral striatal lesions: effect upon the circling response to apomorphine.
    Echols SD
    Life Sci; 1979 Feb; 24(8):691-6. PubMed ID: 571504
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.